Inventor · disambiguated record
Charles A. Mcwherter
Also filed as: MCWHERTER CHARLES · MCWHERTER CHARLES A
44 granted patents·20 pending applications·417 citations·filing 1987–2024
98Inventor score
Files withCYMABAY THERAPEUTICS INC41MONSANTO TECHNOLOGY LLC4MC KEARN JOHN P2PHARMACIA CORP2SONG JIANGAO2
Top patents by PatentIndex Score
64 records- 0196US9616039B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2016·Granted Apr 11, 2017·31 cites·12 claims
- 0296US9381181B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·38 cites·6 claims
- 0396US6639054B1Preparation of deallergenized proteins and permuteinsMONSANTO TECHNOLOGY LLC·Filed 2001·Granted Oct 28, 2003·80 cites·1 claims
- 0494US9486428B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2015·Granted Nov 8, 2016·14 cites·6 claims
- 0592US10512622B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·4 cites·10 claims
- 0691US10188620B2Treatment for NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·7 cites·19 claims
- 0791US9962346B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2017·Granted May 8, 2018·8 cites·13 claims
- 0890US9808436B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2016·Granted Nov 7, 2017·6 cites·9 claims
- 0990US9060987B2Methods for treating gout flaresCYMABAY THERAPEUTICS INC·Filed 2012·Granted Jun 23, 2015·5 cites·16 claims
- 1089US10272058B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2017·Granted Apr 30, 2019·5 cites·16 claims
- 1188US9439891B2Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agentCYMABAY THERAPEUTICS INC·Filed 2015·Granted Sep 13, 2016·3 cites·16 claims
- 1288US9433612B2Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agentCYMABAY THERAPEUTICS INC·Filed 2015·Granted Sep 6, 2016·3 cites·23 claims
- 1388US9023856B2Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agentROBERTS BRIAN K·Filed 2012·Granted May 5, 2015·8 cites·11 claims
- 1488US4829052ASerine protease inhibitorsMONSANTO CO·Filed 1987·Granted May 9, 1989·59 cites·18 claims
- 1587US10813895B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·1 cites·16 claims
- 1686US10828273B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2018·Granted Nov 10, 2020·1 cites·9 claims
- 1786US10722483B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2019·Granted Jul 28, 2020·1 cites·19 claims
- 1886US10342770B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·3 cites·19 claims
- 1985US10813896B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·1 cites·10 claims
- 2085US6730303B1Fused G-CSF and IL-3 proteins and uses thereofPHARMACIA CORP·Filed 2000·Granted May 4, 2004·12 cites·27 claims
- 2184US8410127B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsSONG JIANGAO·Filed 2010·Granted Apr 2, 2013·9 cites·12 claims
- 2282US10220011B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·2 cites·9 claims
- 2381US7381556B2Nucleic acids encoding deallergenized proteins and permuteinsMONSANTO TECHNOLOGY LLC·Filed 2007·Granted Jun 3, 2008·2 cites·14 claims
- 2480US5969105AStem cell factor receptor agonistsFiled 1997·Granted Oct 19, 1999·52 cites·12 claims
- 2579US10478411B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2019·Granted Nov 19, 2019·1 cites·16 claims
- 2678US9801860B2Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agentCYMABAY THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·1 cites·20 claims
- 2777US11596614B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·0 cites·16 claims
- 2875US11000494B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2020·Granted May 11, 2021·0 cites·16 claims
- 2974US11406611B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·0 cites·9 claims
- 3073US11179359B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2020·Granted Nov 23, 2021·0 cites·19 claims
- 3173US6066318AMulti-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factorsSEARLE & CO·Filed 1997·Granted May 23, 2000·22 cites·58 claims
- 3272US11224580B2Treatment of intrahepatic cholestatic diseasesCYMABAY THERAPEUTICS INC·Filed 2020·Granted Jan 18, 2022·0 cites·12 claims
- 3372US6660257B1Circular permuteins of flt3 ligandPHARMACIA CORP·Filed 1997·Granted Dec 9, 2003·26 cites·11 claims
- 3471US10292983B2Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditionsCYMABAY THERAPEUTICS INC·Filed 2017·Granted May 21, 2019·1 cites·22 claims
- 3569US10137112B2Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agentCYMABAY THERAPEUTICS INC·Filed 2017·Granted Nov 27, 2018·0 cites·9 claims
- 3666US2008254484A1Preparation of Deallergenized Proteins and PermuteinsALIBHAI MURTAZA E·Filed 2008·Application pending·0 cites
- 3763US2024252499A1Treatment of uremic pruritusCYMABAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3863US2024252500A1Treatment of chronic pruritic dermatosesCYMABAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3962US2021283078A1Treatment of cholestatic pruritusCYMABAY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4061US9150567B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsCYMABAY THERAPEUTICS INC·Filed 2014·Granted Oct 6, 2015·0 cites·5 claims
- 4161US7238511B2Preparation of deallergenized proteins and permuteinsMONSANTO TECHNOLOGY LLC·Filed 2005·Granted Jul 3, 2007·0 cites·9 claims
- 4261US2004171115A1Multi-functional hematopoietic fusion proteins between sequence rearranged G-CSF receptor agonists and other hematopoietic factorsFiled 2003·Application pending·0 cites
- 4360US2019105291A1Treatment of cholestatic pruritusCYMABAY THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4459US2018055803A1Methods for Treating Gout FlaresCYMABAY THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4558US2022241228A1Treatment of cholangiopathiesCYMABAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4656US2021355065A1CB-0406 tromethamine saltCYMABAY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4756US2021355066A1CB-0406 choline saltCYMABAY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4855US8815886B2Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine saltsSONG JIANGAO·Filed 2013·Granted Aug 26, 2014·0 cites·20 claims
- 4954US2004127410A1Circular permuteins of flt3 ligandFiled 2003·Application pending·0 cites
- 5053US6943002B2Preparation of deallergenized proteins and permuteinsMONSANTO TECHNOLOGY LLC·Filed 2003·Granted Sep 13, 2005·0 cites·8 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →